| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.39B | 57.99B | 58.60B | 48.70B | 40.67B | 30.20B |
| Gross Profit | 22.75B | 22.45B | 24.21B | 21.27B | 18.01B | 11.12B |
| EBITDA | 15.37B | 15.14B | 17.32B | 15.80B | 13.38B | 6.90B |
| Net Income | 8.31B | 8.30B | 10.78B | 10.43B | 8.29B | 3.44B |
Balance Sheet | ||||||
| Total Assets | 95.75B | 98.06B | 98.83B | 72.49B | 64.99B | 54.95B |
| Cash, Cash Equivalents and Short-Term Investments | 21.67B | 21.88B | 17.89B | 22.46B | 21.16B | 11.92B |
| Total Debt | 11.75B | 12.34B | 12.67B | 1.79B | 387.00M | 305.00M |
| Total Liabilities | 22.41B | 24.19B | 28.88B | 13.12B | 12.33B | 9.17B |
| Stockholders Equity | 73.34B | 73.86B | 69.95B | 59.37B | 52.66B | 45.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.15B | -5.83B | 3.58B | 10.59B | 2.51B |
| Operating Cash Flow | 0.00 | 14.18B | 5.64B | 6.06B | 11.95B | 5.68B |
| Investing Cash Flow | 0.00 | -6.81B | -16.20B | -573.00M | -1.55B | -3.71B |
| Financing Cash Flow | 0.00 | -3.96B | 5.32B | -2.79B | -1.71B | -2.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥19.74B | 7.97 | ― | 0.72% | 6.51% | 3.68% | |
81 Outperform | ¥6.88B | 9.00 | ― | 2.80% | 6.02% | 7.39% | |
78 Outperform | ¥112.14B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
76 Outperform | ¥189.86B | 11.03 | ― | 2.50% | -2.46% | -10.72% | |
67 Neutral | ¥92.31B | 17.07 | ― | 3.77% | -5.87% | 24.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥9.79B | 42.22 | ― | 1.65% | 3.96% | ― |